First-in-Human Single and Multiple Dose of KLA578-1 for Injection

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Healthy Volunteers

Interventions

DRUG

KLA578-1 for injection

Intravenous injection, single dose

DRUG

Etopcoxib Tablets

P.O., single dose

Trial Locations (1)

RECRUITING

The Third Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Sichuan Kelun Pharmaceutical Co., Ltd

INDUSTRY